| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Abteilung Innere Medizin IIIKardiologie (S.K., A.G.,
L.B., H.J.), the Abteilung Medizinische Biometrie und Informatik (M.O.),
Universitaetsklinik Freiburg, and the St. Josefs Hospital (W.K.),
Wiesbadenall in Germany.
Methods and ResultsThe present prospective study included
139 consecutive patients with major pulmonary embolism
diagnosed on the basis of clinical, echocardiographic,
and cardiac catheterization criteria. All patients
underwent contrast echocardiography at
presentation. The end points of the study were overall
mortality and complicated clinical course during the hospital stay
defined as death, cerebral or peripheral
arterial thromboembolism, major bleeding, or need for
endotracheal intubation or cardiopulmonary resuscitation.
Patent foramen ovale was diagnosed in 48 patients (35%). These
patients had a death rate of 33% as opposed to 14% in patients with a
negative echo-contrast examination (P=.015). Logistic
regression analysis demonstrated that the only independent
predictors of mortality in the study population were a patent foramen
ovale (odds ratio [OR], 11.4; P<.001) and
arterial hypotension at presentation (OR, 26.3;
P<.001). Patients with a patent foramen ovale also had
a significantly higher incidence of ischemic stroke (13%
versus 2.2%; P=.02) and peripheral
arterial embolism (15 versus 0%; P<.001).
Overall, the risk of a complicated in-hospital course was 5.2 times
higher in this patient group (P<.001).
ConclusionsIn patients with major pulmonary embolism,
echocardiographic detection of a patent foramen ovale
signifies a particularly high risk of death and arterial
thromboembolic complications.
The diagnosis of acute major pulmonary embolism was based on
clinical suspicion of pulmonary embolism as defined below in
combination with at least one of the following criteria: (1)
echocardiographic findings indicating acute pressure
overload in the right side of the heart in the absence of mitral valve
or left ventricular disease and/or (2)
echocardiographic evidence of pulmonary
hypertension or diagnosis of precapillary pulmonary
hypertension on catheterization of the right side of
the heart. Nuclear imaging studies (ventilation-perfusion lung scans)
or pulmonary angiograms were performed in all patients whose
condition was considered stable enough to permit their transportation
from the emergency room or intensive care unit.
For clinical suspicion of acute pulmonary embolism, three or
more of the following findings had to be present: (1) syncope, (2)
tachycardia (heart rate >100 bpm), (3) dyspnea and/or
tachypnea (breathing rate over 24 breaths per minute or need for
mechanical ventilation), (4) arterial hypoxemia (partial
pressure of oxygen <70 mm Hg while breathing room air or
<80 mm Hg under supplemental oxygen of
Echocardiographic detection of acute right
ventricular pressure overload was based on the presence of
(1) a dilated right ventricle (end-diastolic diameter
>30 mm measured from the parasternal short-axis view or a right
ventricle appearing larger than the left ventricle from the apical or
subcostal four-chamber view)10 or (2) right
ventricular hypertrophy (free wall thickness
>5 mm as measured from the parasternal short-axis or the
subcostal four-chamber view) together with an elevation of right atrial
pressure (absence of inspiratory collapse of the inferior
vena cava).
The presence of pulmonary hypertension had to be confirmed by
at least one of the following findings: (1) dilation of the right
pulmonary artery, defined as cross-sectional diameter >12
mm/m2 body surface area on the suprasternal
echocardiogram,11 (2) tricuspid regurgitant jet
velocity of >2.5 m/s on Doppler
echocardiography in the absence of inspiratory
collapse of the inferior vena cava,10
or (3) diagnosis of precapillary pulmonary hypertension on
catheterization of the right side of the heart
(systolic pulmonary arterial pressure
The tricuspid regurgitant jet velocity obtained by continuous-wave
Doppler echocardiography was used to estimate
systolic right ventricular pressure by means of the
simplified Bernoulli equation.12 Invasive
measurement of right atrial, right ventricular, and
pulmonary artery pressures was performed by means of a
Swan-Ganz thermodilution catheter. Finally, scintigraphic confirmation
of pulmonary embolism (ie, definition of a
diagnostic or high-probability lung scan) was based on the
criteria described by Selby et al.13
Contrast Echocardiography and the Diagnosis
of a PFO
Definition of Clinical End Points
Statistical Analysis
Pulmonary artery pressure was measured during bedside
catheterization of the right side of the heart in 61
patients (44%). In 93 patients (67%), systolic right
ventricular pressure (approximately equal to
pulmonary artery pressure) was noninvasively estimated by
Doppler echocardiography as described in
"Methods." Overall, the severity of pulmonary hypertension
could be assessed at the bedside by either of these two methods in 112
patients (81%). In these patients, systolic pulmonary
artery pressure ranged between 32 and 110 mm Hg (mean,
57±18 mm Hg). The good correlation between invasively and
echocardiographically obtained pulmonary artery
pressures as reported by other investigators12
has been confirmed in our laboratory for patients with
pulmonary embolism.10
Right-to-left shunt through a PFO was diagnosed by contrast
echocardiography in 48 patients of the study
population (35%; see the Figure
After diagnosis of acute pulmonary embolism, 57 patients (41%)
were treated with thrombolytic agents according to the
judgment of the clinicians in the emergency room or intensive care
unit. The remaining 82 patients (59%) received conventional heparin
anticoagulation. Thrombolytic treatment was given to 22
patients with and 35 patients without PFO (46% versus 38%;
P=.47).
Predictors of In-Hospital Mortality
Univariate analysis revealed that in-hospital
mortality was more than twice as high in the presence of PFO (33%
versus 14% in patients without atrial communication;
P=.015). Death during the in-hospital phase was also
significantly more frequent in patients with an acute onset of symptoms
related to pulmonary embolism (27% versus 7.1%;
P=.01) and in those presenting with cardiogenic shock
caused by failure of the right side of the heart (52% versus 15%;
P<.001). Logistic regression analysis demonstrated
that after adjustment for the baseline clinical characteristics listed
in Table 1
Patients with severe pulmonary hypertension (systolic
pressure >60 mm Hg) had a mortality rate of 10.3% compared with
23.3% in patients with mild or moderate pulmonary hypertension
(systolic pressure, 32 to 60 mm Hg; P=.13). On
multivariate analysis, the association between
pulmonary artery pressure and the risk of in-hospital death
reached marginal statistical significance in the whole study population
(OR, 3.6:1 for mild to moderate hypertension; P=.10). On the
other hand, death risk was independent of the severity of
pulmonary hypertension in patients with right-to-left shunt
through a PFO (P=.50).
Major Clinical Events and Determinants of a Complicated
In-Hospital Course
PFO was found to be significantly associated with the occurrence of
ischemic stroke, peripheral arterial
embolism, and the need for endotracheal intubation (Table 3
In recent years, contrast transthoracic or
transesophageal echocardiography
was established as a simple, accurate, and safe procedure for the
diagnosis of interatrial communication. Several studies reported a
significant association between echocardiographically
detected PFO and the occurrence of cryptogenic
stroke.6 7 8 23 On the other hand, it is not
entirely clear whether deep vein thrombosis or pulmonary
embolism was also present in the patients of those series. Thus,
the clinical importance of a PFO still continues to be the subject of
debate.24
Transient right-to-left shunt through a PFO can, indeed, occur even in
the presence of normal right-side
hemodynamics.4 14 25 However,
this phenomenon becomes especially prominent in the setting of elevated
right-side pressures.26 27 28 We therefore
hypothesized that patients with major pulmonary embolism and
PFO might be particularly prone to suffer paradoxical embolism with a
substantial impact on their in-hospital morbidity and mortality. In the
present prospective study, we investigated the death rate and the
incidence of arterial thromboembolic events in a patient
population presenting with acute major pulmonary embolism.
All patients underwent contrast echocardiographic
imaging at diagnosis.
The results of the study provide a clear confirmation of our
hypothesis. The death rate of patients with PFO was as high as 33% and
more than twice as high as that of patients without evidence of
right-to-left atrial shunt. According to multivariate
analysis, PFO was associated with more than a 10-fold increase
in death risk and a 5-fold increase in the risk of major adverse events
during the hospital stay. The clinical relevance of these findings is
emphasized by the high frequency of PFO in our study patients (35%),
which is in accordance with the results of autopsy
series.1
The overall mortality rate of our patient population was 21%, and the
frequency of serious in-hospital complications, such as
arterial thromboembolism, major bleeding, need for
endotracheal intubation, or cardiopulmonary resuscitation, was
also very high (45%). These figures are not surprising in view of the
fact that the present study focused on patients with major
pulmonary embolism. Our inclusion criteria required
echocardiographic evidence of acute right
ventricular pressure overload and/or pulmonary
hypertension diagnosed by echocardiography or
catheterization of the right side of the heart.
Definite confirmation of acute pulmonary embolism by
scintigraphic or pulmonary angiographic studies was recommended
by the study protocol but not defined as an inclusion criterion.
Because clinical and hemodynamic instability precluded
the performance of these procedures in 21% of our patients,
diagnostic uncertainty remains a possibility in some cases.
In particular, it cannot be excluded that preexisting pulmonary
hypertension (resulting from recurrent thromboembolism or chronic
pulmonary disease) might have led to right
ventricular pressure overload in some patients. The
differential diagnosis of an enlarged right ventricle also includes
right ventricular myocardial infarction and congenital
heart disease.29 30 These limitations
notwithstanding, a diagnostic strategy based on
echocardiography not only is safe and practicable
in the intensive or emergency care setting but also can lead to rapid
identification31 and probably to more effective
treatment of high-risk patients with acute pulmonary
embolism.32
We found that systolic pulmonary pressure >60
mm Hg was associated with a tendency toward decreased mortality rates
compared with mild or moderate pulmonary hypertension. The
explanation for this finding probably lies in the fact that severe
pulmonary hypertension signifies the presence of chronic right
ventricular pressure overload as previously
demonstrated.33 In a recent study, we could show
that patients with a chronically "adapted," hypertrophied right
ventricle resulting from recurrent thromboembolic events could better
tolerate the hemodynamic consequences of
pulmonary embolism during the acute
phase.34
Conclusions
Presented in part at the 69th Scientific Sessions of the American Heart Association, New Orleans, La, November 1013, 1996, and previously published in abstract form (Circulation. 1996;94[suppl I]:I-129).
Received August 29, 1997;
revision received November 21, 1997;
accepted January 14, 1998.
2.
Meister SG, Grossman W, Dexter L, Dalen JE.
Paradoxical embolism: diagnosis during life. Am J Med. 1972;53:292298.[Medline]
[Order article via Infotrieve]
3.
Cheng TO. Paradoxical embolism: a
diagnostic challenge and its detection during life.
Circulation. 1976;53:565568.
4.
Kronik G, Mösslacher H. Positive contrast
echocardiography in patients with patent foramen
ovale and normal right heart hemodynamics.
Am J Cardiol. 1982;49:18061809.[Medline]
[Order article via Infotrieve]
5.
Lynch JJ, Schuchard GH, Gross CM, Wann LS. Prevalence
of right-to-left shunting in the healthy population: detection by
Valsalva maneuver contrast echocardiography.
Am J Cardiol. 1984;53:14781480.[Medline]
[Order article via Infotrieve]
6.
Lechat P, Mas JL, Lascault G, Loron P, Theard M,
Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of
patent foramen ovale in patients with stroke. N Engl J
Med. 1988;318:11481152.[Abstract]
7.
Webster MWI, Chancellor AM, Smith HJ, Swift DL, Sharpe
DN, Bass NM. Patent foramen ovale in young stroke patients.
Lancet. 1988;2:1112.[Medline]
[Order article via Infotrieve]
8.
Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S.
Patent foramen ovale as a risk factor for cryptogenic stroke. Ann
Intern Med. 1992;117:461465.
9.
Kasper W, Geibel A, Tiede N, Just H. Patent foramen
ovale in patients with hemodynamically significant
pulmonary embolism. Lancet. 1992;340:561564.[Medline]
[Order article via Infotrieve]
10.
Kasper W, Geibel A, Tiede N, Bassenge D, Kauder E,
Konstantinides S, Meinertz T, Just H. Distinguishing between acute and
subacute major pulmonary embolism by conventional and
Doppler echocardiography. Br Heart
J. 1993;70:352356.
11.
Kasper W, Meinertz T, Henkel B, Eissner D, Hahn K,
Hofmann T, Zeiher A, Just H. Echocardiographic findings
in patients with proven pulmonary embolism. Am Heart
J. 1986;112:12841290.[Medline]
[Order article via Infotrieve]
12.
Currie PJ, Seward JB, Chan KL, Fyfe DA, Hagler DJ, Mair
DD, Reeder GS, Nishimura RA, Tajik AJ. Continuous wave Doppler
determination of right ventricular pressure: a
simultaneous Doppler-catheterization
study in 127 patients. J Am Coll Cardiol. 1985;6:750756.[Abstract]
13.
Selby JB, Callcott F, Gordon L, Gardner J. Utility of
Tc-99m DTPA aerosol inhalation scans following perfusion lung scans in
the diagnosis of pulmonary embolism. Clin Nucl Med. 1990;15:143149.[Medline]
[Order article via Infotrieve]
14.
Dubourg O, Bourdarias JP, Farcot JC, Gueret P, Terdjman
M, Ferrier A, Rigaud M, Bardet JC. Contrast
echocardiographic visualization of cough-induced right
to left shunt through a patent foramen ovale. J Am Coll
Cardiol. 1984;4:587594.[Abstract]
15.
Cohnheim J. Thrombose und Embolie:
Vorlesung über allgemeine Pathologie. Berlin, Germany:
Hirschwald; 1877;1:134.
16.
Thompson T, Evans W. Paradoxical embolism. Q
J Med. 1930;23:135150.
17.
Johnson BJ. Paradoxical embolism. J Clin
Pathol. 1951;4:316332.
18.
Nellessen U, Daniel WG, Matheis G, Oelert H, Depping K,
Lichtlen PR. Impending paradoxical embolism from atrial thrombus:
correct diagnosis by transesophageal
echocardiography and prevention by surgery.
J Am Coll Cardiol. 1985;5:10021004.[Abstract]
19.
Loscalzo J. Paradoxical embolism: clinical
presentation, diagnostic strategies, and
therapeutic options. Am Heart J. 1986;112:141145.[Medline]
[Order article via Infotrieve]
20.
Nagelhout DA, Pearson AC, Labovitz AJ. Diagnosis of
paradoxic embolism by transesophageal
echocardiography. Am Heart J. 1991;121:15521554.[Medline]
[Order article via Infotrieve]
21.
Nelson CW, Snow FR, Barnett M, McRoy L, Wechsler AS,
Nixon JV. Impending paradoxical embolism:
echocardiographic diagnosis of an intracardiac thrombus
crossing a patent foramen ovale. Am Heart J. 1991;122:859862.[Medline]
[Order article via Infotrieve]
22.
Hales CA, Johnson RA. Pulmonary thromboembolism
and non-thromboembolic pulmonary vascular disease. In: Eagle
KA, Haber E, DeSanctis RW, Austen WG, eds. Practice of
Cardiology. 2nd ed. Boston, Mass: Little, Brown
and Co; 1989:12991301.
23.
Hausmann D, Mügge A, Becht I, Daniel WG.
Diagnosis of patent foramen ovale by transesophageal
echocardiography and association with cerebral and
peripheral embolic events. Am J Cardiol. 1992;70:668672.[Medline]
[Order article via Infotrieve]
24.
Movsowitz C, Podolsky LA, Meyerowitz CB, Jacobs LE,
Kotler MN. Patent foramen ovale: a nonfunctional embryologic remnant or
a potential cause of significant pathology? J Am Soc
Echocardiogr. 1992;5:259270.[Medline]
[Order article via Infotrieve]
25.
Langholz D, Louie EK, Konstadt SN, Rao TLK, Scanlon PJ.
Transesophageal echocardiographic
demonstration of distinct mechanisms for right to left shunting across
a patent foramen ovale in the absence of pulmonary
hypertension. J Am Coll Cardiol. 1991;18:11121117.[Abstract]
26.
Keidar S, Grenadier E, Binenboim C, Palant A. Transient
right to left atrial shunt detected by contrast
echocardiography in the acute stage of
pulmonary embolism. J Clin Ultrasound. 1984;12:417419.[Medline]
[Order article via Infotrieve]
27.
Higgins JR, Strunk BL, Schiller NB. Diagnosis of
paradoxical embolism with contrast
echocardiography. Am Heart J. 1984;107:375377.[Medline]
[Order article via Infotrieve]
28.
Rodgers DM, Singh S, Meister SG. Contrast
echocardiographic documentation of paradoxical
embolism. Am Heart J. 1984;107:12701271.[Medline]
[Order article via Infotrieve]
29.
Goldberger JJ, Himelman RB, Wolfe CL, Schiller NB.
Right ventricular infarction: recognition and assessment of
its hemodynamic significance by two-dimensional
echocardiography. J Am Soc
Echocardiogr. 1991;4:140146.[Medline]
[Order article via Infotrieve]
30.
Feneley M, Gavaghan T. Paradoxical and
pseudoparadoxical interventricular septal motion in
patients with right ventricular volume overload.
Circulation. 1986;74:230238.
31.
Konstantinides S, Geibel A, Kasper W, Olschewski M,
Kienast J, Iversen S, Grosser KD. Predictors of in-hospital mortality
in patients with acute massive pulmonary embolism: results of
the Management and Prognosis of Pulmonary Embolism Registry.
Circulation. 1996;94(suppl I):I-572. Abstract.
32.
Konstantinides S, Geibel A, Olschewski M, Heinrich F,
Grosser KD, Rauber K, Iversen S, Redecker M, Kienast J, Just H, Kasper
W. Association between thrombolytic treatment and the
prognosis of hemodynamically stable patients with major
pulmonary embolism: results of a multicenter registry.
Circulation. 1997;96:882888.
33.
McIntyre KM, Sasahara AA. Hemodynamic
and ventricular response to pulmonary embolism.
Prog Cardiovasc Dis. 1974;17:175178.[Medline]
[Order article via Infotrieve]
34.
Kasper W, Konstantinides S, Geibel A, Tiede N, Krause
T, Just H. Prognostic significance of right ventricular
afterload stress detected by echocardiography in
patients with clinically suspected pulmonary embolism.
Heart. 1997;77:346349.
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports
Patent Foramen Ovale Is an Important Predictor of Adverse Outcome in Patients With Major Pulmonary Embolism
![]()
Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References
BackgroundRight-to-left shunt
through a patent foramen ovale is frequently diagnosed by contrast
echocardiography and can be particularly prominent
in the presence of elevated pressures in the right side of the heart.
Its prognostic significance in patients with pulmonary
thromboembolism, however, is unknown.
Key Words: embolism echocardiography contrast media shunts
![]()
Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References
The clinical
relevance of a patent foramen ovale (PFO), a relatively frequent
remnant of fetal circulation,1 has remained
obscure for many decades. Before the development of
echocardiographic imaging techniques, detection of PFO
during life and clinical diagnosis of paradoxical embolism were
confined to isolated reports.2 3 During the past
15 years, the initial studies reporting noninvasive detection of
right-to-left atrial shunt by contrast
echocardiography4 5 were
followed by extensive clinical research on the association between PFO
and cryptogenic stroke.6 7 8 However, none of the
major series provided data on those patients who would be expected to
be at particularly high risk of paradoxical embolism, namely patients
with elevated pressures in the right side of the heart caused by acute
major pulmonary embolism. In a previously published report, we
observed that the presence of a PFO in this patient group was
associated with a high incidence of cerebral and peripheral
ischemic events suggestive of paradoxical
embolism.9 Therefore, the aim of the present
prospective study was to test the hypothesis that PFO detected by
contrast echocardiography is an important
prognostic indicator, especially with regard to mortality and the
occurrence of cardiovascular complications during the
acute phase of pulmonary embolism.
![]()
Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References
Study Population
Between May 1988 and December 1994, 1343 consecutive patients
with clinically suspected acute pulmonary embolism either on
admission or during the hospital stay prospectively underwent
two-dimensional and Doppler echocardiographic
evaluation at our institution as part of the initial
diagnostic workup. Of these, 139 patients who were found to
have acute major pulmonary embolism formed the population of
the present study.
2 L/min) in the absence
of pulmonary infiltrates on chest x-ray, and (5) new-onset ECG
signs of strain in the right side of the heart (complete or incomplete
right bundle-branch block, S waves in lead I combined with Q waves in
lead III, or T-wave inversion in the precordial leads
V1 through V3).
35 mm Hg or mean pressure
20 mm Hg in the presence of
normal pulmonary artery occlusion pressure).
All patients in the study population underwent contrast
echocardiographic studies during the initial ultrasound
examination for detection of right-to-left shunt through a PFO. During
visualization of the heart from the apical four-chamber view,
echo-contrast opacification of the right atrium was achieved by rapidly
injecting 10 mL of agitated 5.5% oxypolygelatine solution (Gelifundol,
Biotest Pharma Inc) through an antecubital vein as previously
described.9 Every care was taken to extrude all
macroscopic air from the syringe before injection. Echo-contrast was
considered to be adequate if the entire right atrium remained opacified
for at least three cardiac cycles. The detection of five or more
microbubbles in the left heart cavities within three cardiac cycles
after their appearance in the right atrium was considered
diagnostic of a PFO.14 Informed
consent was obtained from all patients or their first-degree relatives
before administration of the echo-contrast agent. The procedure was
well tolerated in all cases, and no side effects were reported.
Statistical evaluation of the patients' outcome during the
in-hospital period focused on two major clinical end points: overall
mortality and complicated in-hospital course, defined as the occurrence
of one of the following events: death, ischemic stroke,
peripheral arterial embolism, major bleeding,
or the need for endotracheal intubation or cardiopulmonary
resuscitation. The diagnosis of ischemic stroke was confirmed
by CT or autopsy in all cases. The diagnosis of peripheral
arterial embolism was based on clinical, laboratory, and
radiological findings signifying vascular occlusion with renal,
intestinal, or limb ischemia. Finally, major bleeding was
defined as hemorrhagic stroke confirmed by CT or autopsy or as a
bleeding episode that fulfilled at least one of the following criteria:
a decrease in hemoglobin levels of
2 g/dL, requirement for a blood
transfusion of two units or more, retroperitoneal bleeding, or bleeding
that required surgical intervention or discontinuation of heparin
anticoagulation or thrombolytic treatment.
For descriptive purposes, quantitative variables are
presented as mean±SD; qualitative variables, as absolute
and relative frequencies. The prognostic relevance of PFO and other
clinically important variables with respect to mortality and major
in-hospital events was analyzed univariately by
Fisher's exact test. To investigate whether the prognostic effect of
PFO is independent of other clinical variables, a multiple logistic
regression model was additionally applied to the two major end points
(mortality and complicated in-hospital course). The results of the
logistic regression models are presented as estimated odds
ratios (ORs) with the corresponding 95% confidence intervals. All
significance tests were two-sided, with a value of P<.05
considered to indicate clinical significance. Data processing and
analysis were performed with the Statistical Analysis
System.
![]()
Results
Top
Abstract
Introduction
Methods
Results
Discussion
References
Clinical and Echocardiographic Findings at
Diagnosis
The study population consisted of 69 women and 70 men with a mean
age of 59±17 years (range, 17 to 89 years); their clinical
characteristics at the time of diagnosis are shown in Table 1
. Twenty-three patients (17%) had no
known risk factors for venous thromboembolic disease in their
histories. Most patients (70%) presented with an acute onset
of symptoms, ie, <5 days before the diagnosis of pulmonary
embolism. All patients had evidence of pulmonary hypertension
and/or right ventricular pressure overload according to the
aforementioned criteria. Right ventricular dilation was
present in the vast majority of the patients (134, or 96% of the
study population). In addition, echocardiography
detected the presence of thrombi in the right chambers or in the
proximal portions of the right pulmonary artery in 25 patients
(18%). After the initial clinical and
echocardiographic evaluation, nuclear imaging and
pulmonary angiographic studies confirmed the diagnosis of
pulmonary embolism in 86 (62%) and 32 (23%) patients,
respectively. Overall, confirmation of the thromboembolic event was
provided by at least one of these methods or by the autopsy findings in
110 patients of the study group (79%). B-mode and/or Doppler
ultrasonographic or phlebographic studies were performed in 105
patients (76%) and revealed the presence of deep vein thrombosis in 77
of these patients (73%).
View this table:
[in a new window]
Table 1. Clinical Characteristics at
Diagnosis
). There was no
difference in systolic pulmonary pressure between the
patients with and without PFO (58±17 versus 57±19 mm Hg;
P=.60).

View larger version (67K):
[in a new window]
Figure 1. Marked right ventricular (RV) and right atrial
(RA) enlargement could be detected by
echocardiography in this patient with acute, major
pulmonary embolism (top, apical view). After echo-contrast
injection through a peripheral vein, the cavities of the
right side of the heart were adequately opacified (middle). Within
three cardiac cycles, however, complete opacification of the left
atrium and left ventricle (LV) also occurred, indicating massive
right-to-left shunt through a patent foramen ovale (bottom).
The mean duration of hospitalization after the diagnosis of acute
pulmonary embolism was 22±17 days. During this period, 29
patients (21% of the study population) died. Death was directly
related to the acute thromboembolic event in the vast majority of the
cases (25 of the 29 patients; 86%). One patient died of septic shock
on the fourth postoperative day after emergency pulmonary
embolectomy. Another patient recovered from the initial episode of
pulmonary embolism but died of recurrent major
pulmonary embolism 3 days after presentation.
Finally, in-hospital death was due to the underlying disease in 2
patients who had Salmonella osteomyelitis with sepsis and a malignant
tumor, respectively.
and for the echocardiographic detection of
right-side thrombi, PFO and arterial hypotension remained
the only independent predictors of in-hospital death (OR, 11.4 and
26.3, respectively; Table 2
). PFO
remained a significant independent predictor of mortality even if only
those patients with definite confirmation of pulmonary embolism
by lung scan, pulmonary angiography, or autopsy were included
in the statistical analysis (OR, 8.58; 95% confidence
interval, 1.92 to 38.4).
View this table:
[in a new window]
Table 2. Determinants of Outcome in Patients With Acute Major
Pulmonary Embolism
Following diagnosis of acute major pulmonary embolism, 62
patients (45%) suffered at least one of the major in-hospital clinical
events listed in Table 3
.
Ischemic stroke occurred in 8 patients (5.8%), and 7 patients
(5%) suffered a peripheral arterial
thromboembolic event. Major bleeding was documented in 30 patients
(22%), and the occurrence of cerebral bleeding was 2.1%. The
frequency of major bleeding episodes was 32% among 57 patients (41%)
of the study group who received thrombolytic treatment
as opposed to 15% in the remaining 82 patients who underwent
conventional heparin anticoagulation (P=.02).
View this table:
[in a new window]
Table 3. In-Hospital Clinical
Events
). In fact,
the presence of a PFO resulted in a more than fivefold increase in the
adjusted risk of major in-hospital complications (P<.001;
Table 2
).
![]()
Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References
Since its first description by Cohnheim15 in
1877, the entity of paradoxical embolism through a PFO has remained a
diagnostic challenge. Definite confirmation of paradoxical
embolism essentially requires the detection of a right atrial thrombus
crossing the foramen ovale.16 17 However, direct
observation of this phenomenon during life is rarely possible and
remains confined to isolated echocardiographic
reports.18 19 20 21 In clinical practice, the
diagnosis of paradoxical embolism is almost always presumptive and
relies on (1) the occurrence of an arterial thromboembolic
event in the absence of atrial fibrillation, disease of the left side
of the heart, or severe atherosclerosis of the thoracic
aorta; (2) the detection of right-to-left shunt, usually through a PFO
or an atrial septal defect; and (3) the presence of venous thrombosis
or pulmonary embolism.17 22
The results of the present prospective study have, in our
opinion, important clinical implications. They demonstrate that
right-to-left shunt through a PFO is an independent predictor of
adverse outcome in patients with acute major pulmonary
embolism. Thus, detection of PFO by contrast
echocardiography should probably prompt
consideration of aggressive therapeutic options, such as
thrombolytic treatment or catheter thrombus
fragmentation, to restore pulmonary vascular patency and
normalize right-side hemodynamics as soon as possible.
On the other hand, silent paradoxical embolism might increase the risk
of life-threatening hemorrhagic complications of
thrombolysis. These crucial issues need to be addressed
by future controlled trials and will, it is hoped, lead to a more
sophisticated and effective strategy in the treatment of acute
pulmonary embolism.
![]()
Footnotes
Reprint requests to Dr S. Konstantinides, Universitaetsklinik Freiburg, Innere Medizin IIIKardiologie, Hugstetter Str 55, D-79106 Freiburg, Germany.
![]()
References
Top
Abstract
Introduction
Methods
Results
Discussion
References
1.
Hagen PT, Scholz DG, Edwards WD. Incidence and
size of patent foramen ovale during the first 10 decades of life: an
autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:1720.[Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
![]() |
A.-R. Fathi, P. Eshtehardi, and B. Meier Patent foramen ovale and neurosurgery in sitting position: a systematic review Br. J. Anaesth., May 1, 2009; 102(5): 588 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Meier Stroke and migraine: a cardiologist's headache Heart, April 1, 2009; 95(7): 595 - 602. [Full Text] [PDF] |
||||
![]() |
A Wahl and B Meier Patent foramen ovale and ventricular septal defect closure Heart, January 1, 2009; 95(1): 70 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Windecker and B. Meier Patent Foramen Ovale and Cryptogenic Stroke: To Close or Not to Close? Closure: What Else! Circulation, November 4, 2008; 118(19): 1989 - 1997. [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, F. Bengel, A. J.B. Brady, D. Ferreira, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur. Heart J., September 2, 2008; 29(18): 2276 - 2315. [Full Text] [PDF] |
||||
![]() |
E. E. Williamson, J. Kirsch, P. A. Araoz, W. B. Edmister, D. D. Borgeson, J. F. Glockner, and J. F. Breen ECG-Gated Cardiac CT Angiography Using 64-MDCT for Detection of Patent Foramen Ovale Am. J. Roentgenol., April 1, 2008; 190(4): 929 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hara, T. K. Jones, E. R. Ladich, R. Virmani, D. C. Auth, J. E. Eichinger, R. J. Sommer, R. A. Van Tassel, and R. S. Schwartz Patent Foramen Ovale Closure by Radiofrequency Thermal Coaptation: First Experience in the Porcine Model and Healing Mechanisms Over Time Circulation, August 7, 2007; 116(6): 648 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Maier, N. Teucher, H. Dorge, and S. Konstantinides Large emboli on their way through the heart - First live demonstration of large paradoxical embolisms through a patent foramen ovale Eur J Echocardiogr, March 1, 2007; 8(2): 158 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Goueffic, R. Carbajal, M. Burban, and G. Blancho Successful endovascular treatment of bilateral renal artery paradoxical embolus by a modified standard technique Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2315 - 2317. [Full Text] [PDF] |
||||
![]() |
J. L.C. De Keyser, M.-C. Herregods, K. Dujardin, and W. Mullens The Eustachian valve in pulmonary embolism: Rescue or perilous? Eur J Echocardiogr, August 1, 2006; 7(4): 336 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Van Dantzig Echocardiography in the Emergency Department Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2006; 10(1): 79 - 81. [Abstract] [PDF] |
||||
![]() |
P. D. Maldjian and F. S. Chew Imaging of pulmonary embolism: self-assessment module. Am. J. Roentgenol., March 1, 2006; 186(3 Suppl): S215 - S218. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Maldjian, A. Anis, and M. Saric Radiological reasoning: pulmonary embolism--thinking beyond the clots. Am. J. Roentgenol., March 1, 2006; 186(3 Suppl): S219 - S223. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Meier Patent Foramen Ovale, Guilty But Only as a Gang Member and for a Lesser Crime J. Am. Coll. Cardiol., January 17, 2006; 47(2): 446 - 448. [Full Text] [PDF] |
||||
![]() |
B. Ghaye, A. Ghuysen, P.-J. Bruyere, V. D'Orio, and R. F. Dondelinger Can CT Pulmonary Angiography Allow Assessment of Severity and Prognosis in Patients Presenting with Pulmonary Embolism? What the Radiologist Needs to Know RadioGraphics, January 1, 2006; 26(1): 23 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hara, R. Virmani, E. Ladich, S. Mackey-Bojack, J. Titus, M. Reisman, W. Gray, M. Nakamura, M. Mooney, A. Poulose, et al. Patent Foramen Ovale: Current Pathology, Pathophysiology, and Clinical Status J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1768 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zanchetta, G. Rigatelli, and S. Y. Ho A Mystery Featuring Right-to-Left Shunting Despite Normal Intracardiac Pressure Chest, August 1, 2005; 128(2): 998 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
F A Flachskampf and W G Daniel Closure of patent foramen ovale: is the case really closed as well? Heart, April 1, 2005; 91(4): 449 - 450. [Full Text] [PDF] |
||||
![]() |
J. H. Kim, J. B. Seo, K.-H. Do, S. Ko, S.-H. Lee, J. S. Lee, J. W. Song, T.-H. Lim, and K. S. Song Paradoxical Embolism Detected on CT Angiography and Treated With Temporary Inferior Vena Cava Filtration and Anticoagulation Am. J. Roentgenol., November 1, 2004; 183(5): 1244 - 1246. [Full Text] [PDF] |
||||
![]() |
T. O. Cheng Role of Paradoxic Embolism in Patients With Acute Pulmonary Embolism and Right Ventricular Enlargement Who Are at Risk for Adverse Clinical Events Circulation, September 28, 2004; 110(13): e331 - e331. [Full Text] [PDF] |
||||
![]() |
M.R. Loebinger and J.C. Bradley Thrombolysis in pulmonary embolism: are we under-using it? QJM, June 1, 2004; 97(6): 361 - 364. [Full Text] [PDF] |
||||
![]() |
F. Lapostolle, S. W. Borron, V. Surget, D. Sordelet, C. Lapandry, and F. Adnet Stroke associated with pulmonary embolism after air travel Neurology, June 24, 2003; 60(12): 1983 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Henk, S. Grampp, K. F. Linnau, M. M. Thurnher, C. Czerny, C. J. Herold, and G. H. Mostbeck Suspected Pulmonary Embolism: Enhancement of Pulmonary Arteries at Deep-Inspiration CT Angiography—Influence of Patent Foramen Ovale and Atrial-Septal Defect Radiology, March 1, 2003; 226(3): 749 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kearon Diagnosis of pulmonary embolism Can. Med. Assoc. J., January 21, 2003; 168(2): 183 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Meier and J. E. Lock Contemporary Management of Patent Foramen Ovale Circulation, January 7, 2003; 107(1): 5 - 9. [Full Text] [PDF] |
||||
![]() |
S. Konstantinides, A. Geibel, M. Olschewski, W. Kasper, N. Hruska, S. Jackle, and L. Binder Importance of Cardiac Troponins I and T in Risk Stratification of Patients With Acute Pulmonary Embolism Circulation, September 3, 2002; 106(10): 1263 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Z. Goldhaber Echocardiography in the Management of Pulmonary Embolism Ann Intern Med, May 7, 2002; 136(9): 691 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Wood Major Pulmonary Embolism : Review of a Pathophysiologic Approach to the Golden Hour of Hemodynamically Significant Pulmonary Embolism Chest, March 1, 2002; 121(3): 877 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghamande, R. Ramsey, J. F. Rhodes, and J. K. Stoller Right Hemidiaphragmatic Elevation With a Right-to-Left Interatrial Shunt Through a Patent Foramen Ovale : A Case Report and Literature Review Chest, December 1, 2001; 120(6): 2094 - 2096. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hanrath IMAGING TECHNIQUES: Transoesophageal Echo-Doppler in cardiology Heart, November 1, 2001; 86(5): 586 - 592. [Full Text] [PDF] |
||||
![]() |
M. R. Sukernik, B. Mets, and E. Bennett-Guerrero Patent Foramen Ovale and its Significance in the Perioperative Period Anesth. Analg., November 1, 2001; 93(5): 1137 - 1146. [Full Text] [PDF] |
||||
![]() |
V. Karttunen, M. Ventila, M. Ikaheimo, M. Niemela, and M. Hillbom Ear Oximetry: A Noninvasive Method for Detection of Patent Foramen Ovale : A Study Comparing Dye Dilution Method and Oximetry With Contrast Transesophageal Echocardiography Stroke, February 1, 2001; 32(2): 448 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Salem, D. Hartnett Daudelin, H. J. Levine, S. G. Pauker, M. H. Eckman, and J. Riff Antithrombotic Therapy in Valvular Heart Disease Chest, January 1, 2001; 119(1_suppl): 207S - 219S. [Full Text] [PDF] |
||||
![]() |
S. De Castro, D. Cartoni, M. Fiorelli, M. Rasura, A. Anzini, E. M. Zanette, M. Beccia, C. Colonnese, F. Fedele, C. Fieschi, et al. Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications Stroke, October 1, 2000; 31(10): 2407 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Windecker, A. Wahl, T. Chatterjee, A. Garachemani, F. R. Eberli, C. Seiler, and B. Meier Percutaneous Closure of Patent Foramen Ovale in Patients With Paradoxical Embolism : Long-Term Risk of Recurrent Thromboembolic Events Circulation, February 29, 2000; 101(8): 893 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Cheng and S. Konstantinides Paradoxical Embolism • Response Circulation, June 29, 1999; 99 (25): 3323 - 3326. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |